Limited Drug Distribution and Repopulation as Important and Neglected Causes of Drug Resistance in Solid Tumors (NIH-Only) |
|
|---|---|
|
|
|
| Launch in standalone player | |
| Air date: | Tuesday, November 20, 2007, 8:30:00 AM |
| Category: | NCI CCR Grand Rounds (NIH Only) |
| Runtime: | 60 minutes |
| NLM Title: | Limited drug distribution and repopulation as important and neglected causes of drug resistance in solid tumors [electronic resource] / Ian Tannock. |
| Series: | Center for Cancer Research-National Cancer Institute grand rounds |
| Author: | Tannock, Ian. National Institutes of Health (U.S.) |
| Publisher: | [Bethesda, Md. : National Institutes of Health, 2007] |
| Other Title(s): | Center for Cancer Research-National Cancer Institute grand rounds |
| Abstract: | (CIT): Center for Cancer Research - National Cancer Institute Grand Rounds Dr. Ian Tannock is the Daniel E Bergsagel Professor of Medical Oncology at the Princess Margaret Hospital and the University of Toronto. He obtained his PhD from the Institute of Cancer Research, London UK in 1968 and his MD form University of Pennsylvania, Philadelphia USA in 1974. His laboratory-based research is in physiological causes of resistance to chemotherapy in solid tumours and methods of overcoming them. His clinical research has involved studies directed to improving the quality of clinical trials, with a particular interest in use of symptom control and quality of life as endpoints in clinical trials. He has led several large clinical trials for patients with prostate cancer and breast cancer, and recently has undertaken studies of fatigue and cognitive dysfunction associated with chemotherapy. He has received several awards including the 2001 Professor of Survivorship award from the Susan G Komen Breast Cancer Foundation, and the 2003 Harold Warwick prize by the National Cancer Institute of Canada for contributions to cancer control. The primary educational objective of these seminars is to provide new information, ideas, and discussion about timely areas of research with impact on the field of oncology. A secondary educational objective is to elicit participation by individuals from all divisions of the intramural NCI, and thus facilitate more interactions among investigators and groups in the NCI. |
| Subjects: | Cell Proliferation Drug Resistance, Neoplasm Neoplasms--blood supply Neoplasms--drug therapy Treatment Failure |
| Publication Types: | Government Publications Lectures |
| NLM Classification: | QZ 267 |
| NLM ID: | 101322971 |
| CIT File ID: | 14159 |
| CIT Live ID: | 6333 |
| Permanent link: | http://videocast.nih.gov/launch.asp?14159 |